Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency
The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.
Abstract
Although the use of the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency is well established, diagnostic peak GH cut-points for other commonly used GH stimulation tests are less clearly established. Despite that fact, the majority of patients in the United States who are evaluated for GH deficiency do not undergo insulin tolerance testing. The aim of this study was to evaluate the relative utility of six different methods of testing for adult GH deficiency currently used in practice in the United States and to develop diagnostic cut-points for each of these tests. Thirty-nine patients (26 male, 13 female) with adult-onset hypothalamic-pituitary disease and multiple pituitary hormone deficiencies were studied in comparison with age-, sex-, estrogen status-, and body mass index-matched control subjects (n = 34; 20 male, 14 female). A third group of patients (n = 21) with adult-onset hypothalamic-pituitary disease and no more than one additional pituitary hormone deficiency was also studied. The primary end-point was peak serum GH response to five GH stimulation tests administered in random order at five separate visits: ITT, arginine (ARG), levodopa (L-DOPA), ARG plus L-DOPA, and ARG plus GHRH. Serum IGF-I concentrations were also measured on two occasions. For purposes of analysis, patients with multiple pituitary hormone deficiencies were assumed to be GH deficient. Three diagnostic cut-points were calculated for each test to provide optimal separation of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While interpreting GH values, one should also consider multiple factors, including nutritional and hormonal status, exercise, body weight, and age, all of which may influence pituitary GH secretion (85,86).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [86]
Citations
Cites
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“Each one unit increase in BMI has been shown to be associated with a 6% decrease in 24-h GH secretion (35).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 1×
“Obesity suppresses GH release, with 24-h GH levels in obese men reduced by 75% in comparison with age-matched normal weight subjects (34).”
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414 · cited 4×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundInfluentialDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-690 · Cited by 352 · cited 1×
“GH therapy was not administered for at least one month before study entry, based on data that demonstrate that serum IGF-I levels return to nearbaseline within 48 h after cessation of GH (22).”
MethodArginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
Background
Research works printed but not linked: 2
- 1998, AACE clinical practice guidelines for growth hormone use in adults and children., Endocr Pract, 4, 165
- Mausner, 1974, Epidemiology, Philadelphia: W. B. Saunders;, 237
Cited by
Items 401–422 of 422
The accuracy of the arginine growth hormone test in Parkinsonism
Pellecchia, M. T., Pivonello, R., Longo, K., Colao, A., & Barone, P. (2008) · Movement Disorders · doi:10.1002/mds.22149
“A study of the arginine GH test conducted in the US showed 59% of the healthy controls had a peak GH serum level of 3 lg/L, which is below the suggested cut-off point used in the studies of Pellecchia et al.4 We would be interested to see the results of the arginine GH test in controls studied by Pellecchia et al., bu…”
MethodInfluentialHipofunción hipofisaria y trastornos relacionados
Abreu-Lomba, A., González, K. D., Mera, M. A. E., Paredes, A. J., & Delgado-Truque, A. E. (2021) · Revista Colombiana Salud Libre · doi:10.18041/1900-7841/rcslibre.2020v15n1.7279
Aljabri, K. S. (2019) · Open Access Journal of Endocrinology · doi:10.23880/oaje-16000136
“Dynamic tests are currently recommended for the diagnosis of GHD: the insulin tolerance test (ITT) is considered as the reference test [12-15].”
Déficit de hormona de crecimiento en el adulto
Rosero, M. E. P., Mejía, A. F., & Abreu-Lomba, A. (2024) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10228
Short Stature: Beyond Growth Hormone
Tornese, G., Deodati, A., & Plachý, L. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4742-7
van Nieuwpoort, I. C. (2024) · doi:10.5463/thesis.530
A Review of Pituitary Gland for General Physicians
Boutrus, T. S. (2024) · Journal of Internal Medicine and Emergency Research · doi:10.37191/mapsci-2582-7367-5(2)-076
“Recently, macimorelin (ghrelin receptor agonist) has been approved, a poor response (subnormal or no rise in GH) is considered a confirmation of GH deficiency when IGF-1 levels are equivocal and pituitary disease present as explained above [60].”
BackgroundModern Technology Enhances Diagnostic Accuracy and Outcome Assessments
Radke, J. C. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-6684-9313-7.ch007
Management of Adults with Childhood-Onset Growth Hormone Deficiency
Paragliola, R. M., & Salvatori, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_7
Numahata, D., Kojo, K., Ishikawa, S., Kuramae, T., Nakazono, A., Yanagida, K., Nishiyama, H., & Takayama, T. (2025) · Reports — Medical Cases Images and Videos · doi:10.3390/reports8030144
Çömlek, F. Ö., Köstek, H. Y., Dilek, E., & Kökenli, F. T. (2025) · Medicine · doi:10.1097/md.0000000000044442
“[20] In our clinical practice, we evaluate our patients whose peak GH levels are insufficient with L-dopa with a second GH stimulation test, which is usually ITT.”
Popp, K. H., Buchfelder, M., & Stalla, G. K. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21184-3.00001-6
Riehle, F., Lustenberger, S., Christ, E., Monnerat, S., Atila, C., & Christ‐Crain, M. (2025) · Pituitary · doi:10.1007/s11102-025-01577-2
Zacharia, S. S., Cherian, K. E., Thomas, R., & Paul, T. V. (2026) · Indian Journal of Physical Medicine and Rehabilitation · doi:10.4103/ijpmr.ijpmr_46_25
Endokrin Hastalıklara Beyin Cerrahisi Yaklaşımı
Çıtışlı, V. (2026) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub1266.c5157
Cuboni, D., Mocellini, F., Sibilla, M., Lauro, G. D., Varaldo, E., Berton, A. M., Prencipe, N., Ghigo, E., Grottoli, S., Maccario, M., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14092001
“Based on Biller et al. [15], the diagnostic cut-off was later revised, increasing the threshold from 3.0 to 5.0 µ g/L.”
InfluentialChen, L. R., Perry, M. B., Salomon‐Estebanez, M., Livesey, D., Martin, G. P., & Higham, C. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-125247
“26 These studies rarely report whether participants had previous radiotherapy involving the HP axis, and when they do, they seldom examine how test results differ between irradiated and non-irradiated patients.”
GHRH–Arginine GH Stimulation Test
Ergin, A. B., Hamrahian, A. H., Kennedy, A. L., & Gupta, M. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-13048-4_12
Déficit de hormona de crecimiento en la época de transición y en el adulto
Álvarez‐Escolá, C., Cárdenas‐Salas, J., & Fajardo, C. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-538-7.00005-8
Nonfunctioning Pituitary Tumors
Samuels, M. H. (2003) · doi:10.1007/978-1-59259-390-3_5
Self-citation
Metadata
- Authors
- Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L.
- Affiliations
- Harvard University (US)
- Oregon Health & Science University (US)
- University Hospitals of Cleveland (US)
- Cedars-Sinai Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Biller, Beverly M. K.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-05-01
- Volume
- 87
- Issue
- 5
- Pages
- 2067-2079
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2125896595
- Semantic Scholar
- e5209f92424ddb2dfc412b4606bcb9a11bff13d5
- Cited by
- 423
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 25 · 2014: 17 · 2013: 19 · 2012: 17
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- insulin tolerance test, arginine stimulation test, GHRH stimulation test, diagnostic thresholds, sensitivity and specificity, multiple pituitary hormone deficiency, hypothalamic-pituitary disease, insulin-like growth factor I, diagnostic accuracy comparison, pituitary hormone replacement
- MeSH terms
- Adult, Aged, Aging, Arginine, Diagnostic Techniques, Endocrine, Drug Combinations, Female, Humans, Hypoglycemic Agents, Insulin, Insulin-Like Growth Factor I, Levodopa, Male, Metabolic Diseases, Middle Aged, Sensitivity and Specificity, Sex Characteristics, Growth Hormone-Releasing Hormone, Stimulation, Chemical, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.